Do Weight Loss Control Pens Really Work? A Doctor’s guild for weight loss solutions

Struggling to shed those stubborn pounds? You’re not alone. In Hong Kong, approximately 37.4% of adults are considered overweight or obese, despite their efforts to maintain a healthy weight. Conventional diets and exercise routines may not work for everyone, but there’s an emerging alternative: weight loss injections. Utilizing these alongside a balanced, calorie-controlled diet can support significant and sustainable weight loss, ultimately enhancing overall well-being.

In this guide, we will consider various weight loss injections available, their mechanisms of action, respective benefits, and how to determine the best option tailored to your needs.

What Are Weight Loss Injections?

Weight loss injections are self-administered devices that deliver prescription medications aimed at assisting weight management. These medications primarily work by suppressing appetite and slowing digestion, thereby enabling individuals to feel satisfied with smaller quantities of food.

Mechanisms of Action

Weight loss medications such as Saxenda (Liraglutide) and Wegovy (semaglutide) are classified as GLP-1 receptor agonists. They mimic the GLP-1 hormone, which is released post-meal. Originally developed for managing type 2 diabetes, these medications also promote insulin release to lower blood sugar levels while delaying gastric emptying to reduce hunger. As a result, users experience weight loss.

Types of Injectable Weight Loss Solutions

• Saxenda (Liraglutide): Saxenda, the first weight loss pen approved for use, requires daily injections. While effective in curbing appetite, it may be considered less potent than newer alternatives. It is suitable for individuals with a BMI of 35 or higher. Research published in 2022 in JAMA found that those given a daily injection of liraglutide lost 6.4% of their body weight after 68 weeks, while those given a weekly injection of semaglutide lost 15.8% on average.
• Ozempic (Semaglutide): Initially created for treating type 2 diabetes, Ozempic is occasionally used off-label for weight management. Administered weekly, it contains the same active ingredient as Wegovy.
• Wegovy (Semaglutide): Specifically designed for obesity management, Wegovy involves weekly injections and has demonstrated considerable efficacy, making it suitable for individuals with a BMI of 30 or higher. A 2023 study published in the New England Journal of Medicine found that individuals taking semaglutide were 20% less likely to experience major adverse cardiovascular events compared to those taking a placebo.
• Mounjaro (Tirzepatide): A recent advancement in weight loss treatment, Mounjaro targets both GLP-1 and GIP receptors, demonstrating potential for a 20% weight loss in clinical trials. It is particularly relevant for individuals with a BMI of 40 or greater. A 2025 study found that people on tirzepatide lost 20.2% of their body weight over 72 weeks, while those on semaglutide lost 13.7%.

Comparative Efficacy

*For Type II Diabetes only. Off-label use if prescribed for weight loss.

How Do Weight Loss Injections Function?

Weight loss injections utilize medications that mimic natural hormones, signalling feelings of fullness to the brain while slowing gastric emptying. This combination leads to reduced calorie intake, assisting in weight loss.

Key Mechanisms

1. Appetite Suppression: Signals the brain to diminish hunger.
2. Increased Satiety: Prolongs the sensation of fullness after consuming smaller meals.

Balanced Assessment of Weight Loss Pens

Weight loss pens offer a novel approach to managing obesity and promoting weight loss. However, as with any medical intervention, they come with both advantages and disadvantages.

Pros

Benefits of Weight Control Injection:

1. Effective Weight Loss:
   • Many users experience significant weight loss when combined with a healthy diet and exercise.
   • Clinical studies have demonstrated substantial average weight loss percentages, particularly with newer medications.
2. Improved Health Outcomes:
   • Weight loss pens can lead to improvements in obesity-related conditions, such as type 2 diabetes, hypertension, and elevated cholesterol levels.
   • Reducing excess weight may lower the risk of developing cardiovascular diseases.
3. Convenience:
   • Self-administered injections can be easily integrated into daily routines, allowing for greater flexibility in managing weight.
   • Weekly or daily dosing provides options that may suit individual preferences.
4. Appetite Control:
   • These medications suppress appetite and increase the sensation of fullness, making it easier to adhere to dietary changes.
   • Users may find themselves consuming fewer calories without feeling deprived.
5. Ongoing Research and Development:
   • Continuous advancements in pharmacological treatments offer hope for more effective options in the future.

Cons

Risks and Side Effects:

1. Side Effects
   • Common side effects include nausea, gastrointestinal discomfort, and potential metabolic disturbances, which can deter some users from continuing treatment.
   • Serious but rarer side effects, such as pancreatitis or gallbladder issues, may pose health risks.
2. Cost
   • Weight loss pens can be expensive, and insurance coverage varies, which may limit access for some individuals.
   • Long-term use can lead to a significant financial burden, especially for those without adequate insurance.
3. Regaining Weight Post-Treatment
   • Many users experience weight regain after discontinuing the medications, especially if lifestyle changes are not maintained.
   • The psychological aspects of weight management must be considered, as reliance on medications can impact self-efficacy.
4. Eligibility Limitations
   • Not everyone is a suitable candidate; contraindications or personal medical histories may exclude individuals from using these medications.
   • Medical supervision is required, necessitating regular consultations and follow-ups.

5. Potential Stigma

There may be societal stigma associated with medical weight loss treatments, which can affect the psychological well-being of users.

Important Considerations

Eligibility Criteria

Weight loss injections are generally recommended for individuals with:

• A BMI of 30 or above
• A BMI of 27 with coexisting health conditions, such as diabetes or hypertension.

Who Should Avoid Weight Loss Injections?

These medications may not be suitable for individuals with:

• A personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN2).
• A history of pancreatitis.
• Gallbladder disease.
• Pregnant or breastfeeding women.

Duration of Use

Patients may typically use weight loss injections for a maximum of two years. Ongoing evaluations by healthcare providers should inform the appropriateness of continuing treatment based on individual progress and tolerability.

Frequently Asked Questions

• Where do I inject?
  Recommended injection sites include the upper thighs, lower abdomen, or upper arms. It’s advisable to rotate injection sites to minimize irritation.
• Will I gain weight after discontinuation?
  Yes, regaining some weight is common; however, sustaining lifestyle changes can aid in managing this.
• What if I stop the injections?
  You may experience increased appetite and could potentially regain weight lost during treatment.

Conclusion

With weight loss pens like Saxenda, Wegovy, Ozempic, and Mounjaro, individuals have access to effective tools that can significantly enhance their journey toward achieving and maintaining a healthier weight. These injections not only support weight reduction but may also improve overall health markers, thereby decreasing the likelihood of heart disease and other obesity-related health complications.

If you are considering a weight loss injection, consulting an expert can help navigate your options effectively. We can discuss your health history, lifestyle, and weight loss objectives to identify the ideal solution tailored specifically to you.

References

1. Population Health Survey 2020-22. Department of Health, Hong Kong. Over half (54.6%) of adults aged 15-84 are considered overweight (BMI 23.0−<25.0) or obese (BMI ≥25.0), comprising 22.0% and 32.6% respectively. 
2. Balanced Assessment of Weight Loss Pens. 
3. Obesity – Centre for Health Protection. 
4. Non-Communicable Diseases Watch June 2023 – Obesity – Centre for Health Protection. 
5. GLP-1 Agonists: What They Are, How They Work & Side Effects. Cleveland Clinic. 
6. Glucagon-like Receptor-1 Agonists for Obesity: Weight Loss Outcomes, Tolerability, Side Effects, and Risks. PMC. 
7. Research Shows GLP-1 Drugs Are Effective But Complex. UChicago Medicine. 
8. What Are the Contraindications for GLP-1 (Glucagon-Like Peptide-1) Injections Like Ozempic (Semaglutide) or Tirzepatide? Dr.Oracle. 
9. Who Shouldn’t Take GLP-1 Medications? GoodRx. 
10. Tirzepatide – StatPearls – NCBI Bookshelf.